ArticleACS omega2026

Overcoming Docetaxel Resistance in Prostate Cancer by Targeting Cell Cycle Progression with Narciclasine-Based Compounds.

Ranyelison Silva Machado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.